This international symposium commemorates three decades of breakthroughs in epigenetics — from the landmark discovery of GCN5/HAT activity to the translation of chromatin mechanisms into therapeutic innovation.
The Peptide Design Competition (PDC) is trying to design a new drug for conditions like obesity and diabetes.
